Enhance MD vs Sprout Health: Pricing, Speed, and Compounds
Enhance MD vs Sprout Health is a clear competition between entry cost and onboarding speed. Early verdict: if you prioritize the lowest first-month price and access to both semaglutide and tirzepatide, Enhance MD leads; if you want lightning-quick approval and an outcome-focused pitch, Sprout Health is the faster, higher-cost option.
Start with Enhance MD from $49 first month
Side-by-side snapshot: Enhance MD vs Sprout Health
| Criteria | Enhance MD | Sprout Health |
|---|---|---|
| First-month price | Semaglutide from $49; Tirzepatide from $99 | $50 off first month, bringing it to $199 |
| Ongoing pricing | Flat-rate pricing; ongoing rate stays the same at every dose (published ongoing rates vary) | $249/month ongoing after discount |
| Compound options | Compounded semaglutide and compounded tirzepatide available on one platform | Compounded semaglutide offered; no branded products published |
| Onboarding speed | Clinician-directed review process; standard telehealth intake | Lightning-quick approval and fast, low-friction entry |
| Outcome framing | No specific outcome guarantee published in source | Frames outcomes as 10–26% body weight loss in 12 months (no formal guarantee) |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Pricing and value: entry cost versus ongoing cost
Enhance MD emphasizes very low entry pricing: semaglutide from $49 first month and tirzepatide from $99 first month. The provider highlights flat-rate pricing so the price stays the same at every dose with no fee escalation during titration. Sprout Health markets a $50 first-month discount that brings the initial cost to $199, with a stated ongoing price of $249/month after the discount. If your priority is the lowest possible first-month outlay and predictable dosing cost structure, Enhance MD is presented as the budget leader; if you accept a higher ongoing cost for a simple initial price and quick start, Sprout Health is the alternative.
See Enhance MD flat-rate pricing
Compound options and platform scope
Enhance MD is notable for offering both compounded semaglutide and compounded tirzepatide on the same platform. The source states this dual-compound availability helps patients who are still deciding between the two compounds. Sprout Health’s source describes compounded semaglutide availability but does not list tirzepatide on the captured materials. Both providers’ materials note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Onboarding speed and experience
Sprout Health pitches a lightning-quick approval process and a fully online, fast-entry experience. The source frames Sprout Health as well-suited to patients who want minimal onboarding friction. Enhance MD uses a clinician-directed review process and emphasizes its patient volume (10,000+ patients treated) but does not claim the same lightning-quick approval timeline in the captured evidence.
Start quickly with Sprout Health
Outcome messaging
Sprout Health frames outcomes around a 10–26% body weight reduction over 12 months, while its source also notes that individual results vary and it does not publish a formal outcome guarantee. Enhance MD’s captured materials focus on pricing, flat-rate dosing, and clinical volume; no specific percentage outcome framing is supplied in the captured evidence.
Regulatory and clinical qualifiers
Both sources stress that treatment is available only when a licensed clinician determines it is medically appropriate. Both also state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Enhance MD additionally notes its medications are clinician-directed and that its compounds are compounded rather than branded finished products.
Learn Sprout Health enrollment details
Which differences matter most
- Entry price: Enhance MD starts semaglutide at $49 first month and tirzepatide at $99 first month; Sprout starts at $199 after a $50 discount.
- Pricing model: Enhance MD advertises flat-rate pricing that does not increase with dose; Sprout Health publishes a higher ongoing $249/month rate after discount.
- Compound options: Enhance MD offers both semaglutide and tirzepatide on one platform; Sprout Health’s captured evidence focuses on semaglutide.
- Onboarding speed: Sprout Health emphasizes lightning-quick approval; Enhance MD highlights clinician-directed review and broad patient volume.
- Outcome framing: Sprout Health cites 10–26% weight-reduction framing over 12 months; Enhance MD does not publish a specific outcome percentage in the captured evidence.
Conclusion: Choose based on cost, compounds, or speed
Enhance MD vs Sprout Health boils down to low entry price and multi-compound access versus faster approval and outcome-focused marketing. Choose Enhance MD if you want the lowest first-month pricing and access to both semaglutide and tirzepatide on one platform with flat-rate dosing. Choose Sprout Health if you want lightning-quick approval and a clear outcome framing with a first-month discount that brings the initial price to $199.